Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.37 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.37 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.37 |
| ▸ | DAGLB | Q8NCG7 | 1/20 | 0.37 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12889352 | 0.77 | CHRNB2 (0.36) | EPHX1 | |
| SCHEMBL161562 | 0.71 | ALOX15 (0.34) | FAAH | |
| SCHEMBL29008700 | 0.70 | ALDH1A1 (0.44) | ACHEKMT2AEPHX1 | |
| SCHEMBL9381457 | 0.68 | EPHX1 (0.54) | ACHEEPHX1 | |
| SCHEMBL9387448 | 0.68 | EPHX1 (0.54) | ACHEEPHX1 | |
| SCHEMBL9382540 | 0.67 | EPHX1 (0.53) | ACHEEPHX1 | |
| SCHEMBL16126195 | 0.65 | ALDH1A1 (0.39) | ACHEKMT2AMEN1FAAHABHD16A | |
| SCHEMBL14480342 | 0.64 | ACHE (0.50) | ACHEEPHX1TDP1 | |
| SCHEMBL1023071 | 0.64 | ACHE (0.61) | ACHEEPHX1 | |
| SCHEMBL12417367 | 0.64 | ACHE (0.61) | ACHEEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220009934-A1 | NOVEL CARBAMATE ESTER COMPOUND AND ACRYLIC RUBBER COMPOSITION CONTAINING THE SAME | UNIMATEC CO., LTD. (JP) | 2022-01-13 | — | — | US | disclosed |
| US-8288483-B2 | Diurethane compound, process for producing the same, and acrylic rubber composition containing the same | UNIMATEC CO., LTD. (JP) | 2012-10-16 | — | — | US | disclosed |
| US-20110040043-A1 | NOVEL DIURETHANE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ACRYLIC RUBBER COMPOSITION CONTAINING THE SAME | UNIMATEC CO., LTD. (JP) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220009934-A1 | NOVEL CARBAMATE ESTER COMPOUND AND ACRYLIC RUBBER COMPOSITION CONTAINING THE SAME | NCEH1, SUV39H1, CCNH | ACHE 621/4885KMT2A 1033/4885MEN1 3239/4885 |
| US-20110040043-A1 | NOVEL DIURETHANE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ACRYLIC RUBBER COMPOSITION CONTAINING THE SAME | NCAPH, ODC1, CTH | ACHE 4304/4885KMT2A 893/4885MEN1 1539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.